A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Status
- RECRUITING
- Phase
- PHASE3
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
- Status
- RECRUITING
- Phase
- PHASE3
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
- Status
- RECRUITING
- Phase
- PHASE1
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
JS212 Combination Therapies in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of IBI310 and Sintilimab Combination Therapy in Patients With Hepatocellular Carcinoma as First-line Treatment.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- NA
A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE2